The Therapeutic Goods Administration (TGA) has published a safety advisory regarding emerging reports of gastrointestinal symptoms associated with the ingredient Withania somnifera (also known as Ashwagandha). Some consumers experience mild gastrointestinal symptoms to herbal ingredients including Withania. The TGA safety advisory reports that Withania somnifera has caused more severe gastrointestinal symptoms such as nausea, vomiting or diarrhoea in some cases and in very rare cases, possible liver injury. 

To read more, please click here.